If you have the axe analyst in a space, you're more likely to be on the deals. The management teams know who the best sell-side analysts that cover them are. As long as you have a good reputation and are "buy rated", they'll probably bring their business to your bank. This is why the vast vast majority of sell-side ratings are horseshit. It also helps if they ask "tee-ball" questions on earnings calls instead of asking actual difficult questions that may make the management teams look bad (in some cases).

 
researchresearch:

Seems to me we normally get told to start covering a company when the IBD division brings in a capital markets/M&A deal rather than the other way round

You're clearly missing the big picture. Janky is right.

Under my tutelage, you will grow from boys to men. From men into gladiators. And from gladiators into SWANSONS.
 
Dece:

Thanks for the reply. Can you just explain how there is an impact on IPOs? Research analysts wouldn't cover a private company, right?

Management wants to be covered by a well respected analyst on the street. If your bank has an analyst that's good and is bullish on the sector, your bankers may have a leg up while pitching. Private or public doesn't matter. Management teams don't live under a rock and they know who has a good research franchise when selecting their IPO book runners (plus it's usually part of the pitch anyway. i.e. research coverage is usually implied or even guaranteed by the bankers).

Under my tutelage, you will grow from boys to men. From men into gladiators. And from gladiators into SWANSONS.
 
Flake:
Dece:

Thanks for the reply. Can you just explain how there is an impact on IPOs? Research analysts wouldn't cover a private company, right?

Management wants to be covered by a well respected analyst on the street. If your bank has an analyst that's good and is bullish on the sector, your bankers may have a leg up while pitching. Private or public doesn't matter. Management teams don't live under a rock and they know who has a good research franchise when selecting their IPO book runners (plus it's usually part of the pitch anyway. i.e. research coverage is usually implied or even guaranteed by the bankers).

I would add that one of the unwritten responsibilities of an analyst is to build relationships with privates and VCs. Also, during due diligence analysts meet with management teams from privates.

 
Best Response
Dece:

How often would research analysts meet with private companies/VC? Or is it something that is mainly done during the pitching process?

I wouldn't have thought that research would be involved in the pitch directly as it is material non public info?

I had to attend an analyst meeting with the management of a potential IPO as part of a vetting process and I know all of the trips my analyst makes but I've never heard of an analyst speaking to a private company just for shits and giggles/when it's not related to a due diligence assignment. I have also never heard of any analyst speaking to VCs or that being part of our regular business. Management of a private company that's not planning on going public any time soon (with your bank as one of the underwriters) doesn't have to tell you shit to be honest and they often can't discuss anything unless you were already wall crossed on the deal.

Maybe if it's some sort of supplier or customer of one of the companies you actually do cover, it may be worth looking into as part of routine due diligence etc. but even then they would probably only tell you what they already disclosed.

Also, you are correct on that last part. We can't be involved in the pitch or help source deals. All we can do is give our banking contact information but we are not even allowed to tell the bankers to expect a call or brief them on who will be reaching out to them. It's all very strict.

Under my tutelage, you will grow from boys to men. From men into gladiators. And from gladiators into SWANSONS.
 

Et voluptatum soluta assumenda consequatur ut. Reprehenderit quisquam ea velit in. Et repudiandae voluptatem necessitatibus incidunt. Optio ea sed voluptas vero ea animi.

Sunt sed et sunt sed hic quis. Et quas consequatur praesentium quisquam aliquid fugiat doloribus. Illum nihil quos odit dolorum ducimus consequuntur.

Career Advancement Opportunities

March 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. (++) 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

March 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

March 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

March 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (86) $261
  • 3rd+ Year Analyst (13) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (202) $159
  • Intern/Summer Analyst (144) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
Betsy Massar's picture
Betsy Massar
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
kanon's picture
kanon
98.9
6
CompBanker's picture
CompBanker
98.9
7
dosk17's picture
dosk17
98.9
8
DrApeman's picture
DrApeman
98.9
9
GameTheory's picture
GameTheory
98.9
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”